Warhound Secures $200 Million to Breed Genetically Engineered Working Dogs Equipped With Tactical Tech

image 172

Biotech venture Warhound has exited stealth mode with $200 million in funding at a $1.2 billion valuation, aiming to produce genetically engineered working dogs for defense personnel, law enforcement, and emergency response units. Backed by investors including In-Q-Tel, Sequoia, and 8VC, the startup was conceived by Colossal Biosciences chief executive Ben Lamm and Anduril co-founder Palmer Luckey.

Warhound plans to tackle a critical shortage of capable canines in national security roles, where more than 80 percent of working dogs currently deployed by the U.S. military originate from Europe, and less than half ultimately qualify for service. To improve performance and eliminate hereditary vulnerabilities such as hip dysplasia, cancer, and vision impairment, the company is assembling cell lines from German Shepherds and Belgian Malinois into a biobank. Scientists will then edit the animals’ genomes to boost health, stamina, agility, and scent detection before cloning them using technology from Colossal subsidiary Viagen.

In parallel with the biological engineering, Anduril will supply specialized hardware and software gear. Tactical accessories, such as protective goggles and sensor-laden bulletproof vests, are designed to feed real-time environmental data back to human handlers to improve situational awareness and field coordination.

The company expects its inaugural batch of cloned puppies to be born early next year, with the goal of deploying them into service within two years. Warhound has held briefings with various government entities and is developing its canine training guidelines alongside the American Humane Society, which will also facilitate post-service adoptions through its working dog retirement programs.

Source: TechCrunch